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1. Introduction 
In the daily clinical routine, clarification of menstrual irregularities is one of the major 
essentials for consultation in gynaecological practice. For an effective therapy, it is 
necessary to know the exact cause of the bleeding disorders. Menstrual irregularities can 
be the expression of a disturbed ovarian function or another disorder, usually uterine 
pathology. The type of menstrual irregularity is not necessarily indicative of the 
underlying disorder so that the examination of the levels of hormones is indispensable. 
Moreover, an organic cause of the bleeding disorder should be excluded. Whether the 
ovulatory cycle is associated with normal follicle maturation and corpus luteum function 
has to be clarified in the treatment of childlessness. The existence of anovulatory cycles or 
cycles with corpus luteum insufficiency can be normal in specific phases of life, e.g., 
puberty or peri-menopause. The issue of therapy should be addressed briefly. Firstly, the 
symptoms such as bleeding disorders and the disease patterns which are responsible for it 
should be highlighted. The clarification of menstrual irregularities is not only important 
in sterility therapy, they also influence the quality of life (1). Furthermore, hormonal 
disorders which are associated with chronic oestrogen or progesterone deficiency have an 
impact on the overall health (2). The following review represents the diagnostics of 
hormone-related menstrual irregularities in the fertile phase of life. The issue of bleeding 
disorders with the application of hormone preparations is not addressed. 
2. Diagnostics of menstrual irregularities 
Menstrual irregularities or bleeding disorders also include menstrual cycle-related 
symptoms such as dysmenorrhoea (1). During the classification of menstrual irregularities 
and/or bleeding disorders the only symptom which is assumed is bleeding, however, it 
does not contain any information about the cause of the deviation from regular menstrual 
cycles. A regular menstrual cycle with a 28-day bleeding interval in 85–90% of the cases is 
usually associated with normal ovarian function and corresponding ovulatory cycles (3). 
The normal bleeding duration is between 3–7 days and is associated with a blood loss of 
30–40 ml (1). Deviations in the form of menstrual bleed which occur too infrequently or 
too frequently can be the expression of a pathological disorder. The causes can be uterine 
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pathology, other illnesses or ovarian dysfunction. It can be assumed that 90% of all 
bleeding disorders are hormone-related or partly hormone-related (4). The menstrual 
irregularity can express itself through a change of the bleeding pattern (menstrual rhythm 
abnormalities), the intensity of bleeding, its duration (type of menstrual abnormalities) or 
in the form of additional bleedings. The bleeding disorders are to be interpreted with the 
age and/or the reproductive phase of the woman, respectively. An oligomenorrhoea in a 
26-year-old obese patient is most likely to be due to a PCO syndrome. However, in a 46-
year-old patient it probably indicates a perimenopausal condition. The physiological 
and/or the therapeutic menstrual irregularities must be disassociated from the 
pathological menstrual irregularities, e.g., the oligomenorrhoea in the perimenopause or 
the amenorrhoea under gestagen monotherapy. 
3. Medical history 
Whilst reviewing the medical history, all previous and current diseases (disorders of the 
liver or kidney function, autoimmune diseases) are inquired about. The current 
complaints, the medication (influence of prolactin production) and the questions 
concerning androgen-induced disorders are just as important questions as the questions 
concerning contraception, desire to have children or previous pregnancies. Lifestyle 
(sleep, physical activity) and eating habits must not be underestimated because 
endocrinological problems occur frequently in both overweight and underweight women 
as well as in the competitive athletes. Even extreme weight fluctuations can have an 
impact on the ovarian function. In this conjunction, the extremely important question 
concerns the coagulation dysfunctions because the execution of anticoagulation can 
influence the bleeding duration and intensity. Furthermore, questions should be asked 
about the presence of endocrinopathies such as diabetes mellitus (type I), Addison 
disease, Cushing disease, previous operation on the uterus and or the ovaries and/or 
operation or trauma of the pituitary area. 
4. Menstruation history 
During the medical history, attention should be paid to the exact increase in bleeding 
intervals. The patients often view their menstrual cycle is normal even if the intervals 
between them do not correspond to the standard of 24 to 34 days. However, a menstruation 
calendar can address the intervals, duration and the intensity of the bleeding. The 
estimation of the bleeding intensity is strongly influenced, therefore, number of sanitary 
towels and/or tampons per day is advised to be recorded. If lower abdominal pain is 
indicated then it is important to observe the temporal relation with the periods. A 
dysmenorrhoea can be a sentinel for an endometriosis. Premenstrual complaints such as 
headaches or mood swings can be the sign of premenstrual syndrome, an indication of 
corpus luteum insufficiency. 
5. Clinical examinations 
It is important to note that an acyclic vaginal bleeding does not always need to be an 
expression of a disturbed ovarian function. A large number of other factors, e.g., colpitis, 
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ectopy, disturbed pregnancy or malignancies can become noticeable through a bleeding 
from the vagina and can often be diagnosed through the use of a speculum and/or a 
vaginal sonograpy. Physical and a gynaecological examination cannot be avoided during 
the diagnostic investigation of menstrual irregularities. The Body-Mass-Index, fat 
distribution pattern as well as androgen-induced disorders are very important, 
particularly in conjunction with the suspicion of PCO syndrome. During the 
gynaecological examination, infections, new formations or malformations of the internal 
genitals can be detected or excluded. Myomas, polyps or carcinomas should not be 
excluded as a cause for the bleeding. The vaginal sonography represents a substantial 
diagnosis test. By doing so, the condition and size of the uterus, endometrial thickness 
and the amount of layers as well as the form and the size of the ovaries can be assessed 
reliably. Follicular presence or absence is a good diagnostic criterion in assessing the egg 
cell reserve of the ovaries. 
6. Hormonal diagnosis 
Suspected diagnoses can usually be made through the type of the menstruation irregularity, 
symptoms and the results of the gynaecological examinations, which can then either be 
confirmed or excluded through a differentiated laboratory diagnosis. Therefore, an obese 
patient with secondary oligomenorrhoea and polycystic ovaries most likely suffers from 
PCO syndrome or a hyperandrogenemia. Conversely, a slim competitive athlete with a 
secondary amenorrhoea probably suffers from hypogonadotropic ovarian insufficiency. The 
menstrual phase must be taken into consideration when a blood sample is taken for 
investigation. It is proved to be useful to carry out the examination in the early follicle phase 
that is 3rd–5th days of menstruation. In secondary amenorrhoea, the question of selecting 
menstrual phase does not arise. The interpretation of hormones within the framework of the 
menstrual events implies the knowledge of the day of menstruation, the length of 
menstruation, the sequential secretion of the individual hormones during the course of a 
menstrual cycle and the relationship to one another (2, 8). The following hormones can be 
determined during the basic diagnostics (basic hormone analysis, [BHA], 3rd–5th days of the 
menstrual cycle). The following blood test should be done in a stress-free morning in early 
follicle phase: 
 FSH (follicle-stimulating hormone) 
 LH (luteinizing hormone) 
 E2 (estradiol) 
 Progesterone 
 Prolactin 
 Testosterone 
 Androstenedione 
 DHEAS (dehydroepiandrosterone sulphate) 
 17-OH-Progesterone 
 TSH (thyroid-stimulating hormone) 
Depending on the assumed disease pattern, not all hormones need to be examined, rather it 
can be limited to the most relevant ones (see below). Table 1 shows the normal values of 
these hormones. 
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Hormone Normal values 
FSH 2 – 10 mIU/ml 
LH 2 – 10 mIU/ml 
Estradiol 25-200 pg/ml 
Progesterone < 1.0 ng/ml > 12 ng/ml in luteal hase 
Prolactin < 10 ng/ml 
Testosterone < 0.4 ng/ml 
DHEAS < 3.0 µg/ml 
Androstendion 0.47–2.68 ng/ml 
17-OH-Progesterone 0.2–1.0 ng/ml 
TSH 0.2–3.5 µIU/ml 
Table 1. Normal values of basic hormone analysis [BHA], 3rd–5th days of the menstrual 
cycle (3, 6) 
7. Monitoring the menstrual cycle 
If a largely inconspicuous menstrual rhythm is present, it is interesting in sterility diagnosis 
to see whether it really leads to ovulation or to a stable luteal phase. Follicle maturation 
disorder or corpus luteum insufficiency cannot be diagnosed through only one single blood 
test. Several examinations concerning the menstrual cycle are necessary. In this connection, 
the vaginal sonography can be implemented in addition to the laboratory diagnosis. One 
would expect the following values in such a diagnostic cycle: 
 Day 3-5: BHA values are normal (see Table 1) 
Vaginal sonography: small endometrium , ovaries with a few  
small preantral follicles 
 Day 12-14: LH normal or ↑, estradiol > 150 pg/ml 
Vaginal sonography: endometrium approx. 10 mm, mostly  
three-layered, dominant follicle approx. 16-20 mm 
 Day 21: Progesterone > 10 ng/ml 
Vaginal sonography: endometrium approx. 10 mm, homogeneous,  
Corpus luteum with interior echoes 
In the case of deviations, conclusion about the underlying disorder can be drawn. The 
carrying out of LH-urine tests for the determination of ovulation period which indicates 
the pre-ovulatory LH surge in the spontaneous menstrual cycle is in practice (5). Both the 
FSH levels and FSH/LH ratio (for values > 3.6 a reduced build up of follicles must be 
expected) as well as the AMH (Anti-Müller hormone) are used for evaluation of the 
ovarian reserve.  
8. Practical approaches to the individual menstrual irregularity 
In 1987, Hammerstein tried to classify the bleeding disorders according to their causes (9). 
This is how the functional (physiological) bleedings are differentiated from dysfunctional 
(hormonal cause) bleedings. Furthermore, iatrogenic (contraception, HRT) systemic 
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(systemic diseases such as coagulation disorders) bleedings are differed from organic 
(carcinoma, myoma, polyp) bleedings. Our suggestion is however, to classify the bleeding 
disorders according to the usual patterns and then to search for their causes (7). If a 
hormonal disorder is responsible instead of an organic disorder, the type of ovarian 
disorder can be defined more precisely, e.g., oligomenorrhoea in the case of PCO syndrome 
(WHO II) or secondary amenorrhoea in the case of hyperprolactinaemia (WHO VI). In the 
case of the following suggestions with regards to the practical approach, it is essential that 
an organic cause for the bleeding disorder (myoma, carcinoma, infection, coagulation 
disorder) has been excluded.  
8.1 Primary amenorrhoea 
The clarification of the primary amenorrhoea is not addressed here in greater detail. What 
is of greater importance than hormone diagnostics is the evaluation of secondary sexual 
characteristics. For example, if the breasts and pubic hair of a 17-year-old patient are 
normal it can be assumed that she has normal ovarian functions. In most cases a diagnosis 
(e.g., hymenal atresia or Mayer-Rokitansky-Küster syndrome) can be made through an 
exact evaluation of the internal sexual characteristics. If the secondary sexual 
characteristics are inadequately pronounced (infantile, virilised), a large number of 
diseases must be considered (delayed puberty, Turner syndrome, androgen receptor 
defects) whose clarification should at best be carried out in a special endocrinological 
consultation. 
8.2 Secondary amenorrhoea 
If the period fails to appear for more than three months although a spontaneous 
menstruation took place previously, then one speaks of a secondary amenorrhoea. It goes 
without saying that in this situation a pregnancy must be excluded. In order to prove at 
which level the disorder has occurred, the provision of the following hormone analysis 
should be adhered to: 
 FSH, LH, estradiol, testosterone, androstendione, DHEAS, prolactin and TSH 
At the same time, the sonographic image of the ovaries and the endometrium is relevant. 
The FSH, LH and estradiol values should be correlated with the sonographic image of the 
internal genitalia because the levels of the individual hormone are extremely variable on 
phases of the menstrual cycle and in the case of amenorrhoea one does not have a reference 
point for the last bleeding. In the case of increased FSH, LH and estradiol values for 
example, a highly established three-layered endometrium is present then one should rather 
think of a periovulatory than a perimenopausal situation. For the further diagnostic 
investigation, a menstrual cycle should be waited for or initiated (2).  
8.3 Oligomenorrhoea 
If possible, a basic diagnosis should be carried out on the 3rd–5th days of menstruation. The 
diagnostic investigation is not substantially different from the clarification in the case of the 
secondary amenorrhoea. Due to the clinically suspected PCO syndrome, the 17-OH-
progesterone should also be codetermined. If it is increased, then a late-onset AGS 
(androgenital syndrome) can cause the symptoms. An ACTH test and a molecular-genetic 
clarification, if possible, would be necessary for further diagnostics. 
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 FSH, LH, estradiol, testosterone, androstendione, DHEAS, prolactin, 17-OH-
progesterone and TSH 
 If blood sampling is not possible in early follicle phase of the menstrual cycle, in 
addition, progesterone should be codetermined.  
8.4 Polymenorrhoea 
Most of the polymenorrhoeas are an expression of corpus luteum insufficiency, which in 
turn is due to a follicle maturation disorder. A normal luteal phase lasts for approx. 14 days, 
in case of duration of 10 days, an insufficient luteal phase can be assumed. Polymenorrhoeas 
however, can also occur in the case of a chronic anovulation as occurs in PCO syndrome. If a 
perimenopausal situation is present, one can limit it to the determination of FSH, LH and 
estradiol, otherwise a clarification as with oligomenorrhoea should take place. 
 FSH, LH, estradiol, testosterone, androstendione, DHEAS, prolactin, 17-OH-
progesterone and TSH 
 Determination of progesterone in the mid-luteal phase for the demonstration of a 
corpus luteum insufficiency  
8.5 Metrorrhagia and menorrhagia 
In 30% of the cases, metrorrhagias have organic causes, 70% of the causes have to do with a 
dysfunctional bleeding which was triggered by persistent follicles or other hormonal 
disorders (1). Organic causes however include infections, myomas, carcinomas or 
coagulation disorders. Defining a bleeding disorder in a perimenopausal situation is 
difficult because it is often difficult to allocate it to one menstrual cycle (7). Metrorrhagias 
and menorrhagias often occur in the transitional phases such as puberty or perimenopause. 
If the progesterone challenge remains absent despite the high estradiol concentration as 
with the follicle persistence, the over-proliferated endometrium is rejected. A stepwise 
diagnostic investigation is recommended:  
 FSH, LH, estradiol 
 Determination of progesterone at mid-luteal phase for the demonstration of corpus 
luteum insufficiency  
 Possible further search for the causes through a complete BHA 
8.6 Supernumerary bleeding 
All forms of the bleeding are referred to as ‘supernumeray bleedings’ which occur 
cyclically and in addition to the normal menstrual bleeding. A distinction is made 
between premenstrual, postmenstrual or ovulational bleeding depending on the time of 
its occurrence. These bleedings are also referred to as ‘spitting’, and its duration is less 
than three days. A premenstrual spotting is usually due to a relative progesterone 
deficiency, and a postmenstrual spotting can be indicative of a very low estradiol 
production. Both of these can be an expression of a follicle maturation disorder and/or 
the former can be due to corpus luteum insufficiency. An ovulational bleeding can be 
caused by a rapid post-ovulatory estradiol deficiency. Supernumerary bleedings can also 
be due to organic causes such as polyps, myomas, carcinomas, infections or coagulation 
disorders. If there is no desire to have children and if there is no strong indication of an 
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endocrinopathy, a diagnostic investigation in the form of hormone analysis is not 
essential because a symptomatic therapy with a hormone preparation usually leads to the 
satisfaction of the patient. 
8.7 Type of menstrual abnormalities 
In the case of the differential diagnosis clarification of hypomenorrhoeas or 
hypermenorrhoea, it should be noted that heavier bleeding is often triggered by a uterus 
myomatosus or a long-term anticoagulation. If an organic and/or systemic cause is 
excluded, a symptomatic therapy is preferred. As a general rule, a hormone analysis is not 
necessary, except when there is the desire to have children. 
9. Differentiation of ovarian dysfunctions 
Menstrual irregularities (deviations from the regular four-week bleeding intervals) are 
usually accompanied by an ovulatory disorder so that one cannot consider the entities, 
menstrual irregularities and ovulational disorders separately. The bleeding disorder is the 
external sign that a possible disturbed ovarian function is present. The definition is purely 
descriptive (7). However, as has already been mentioned, other factors can be responsible 
for the deviation from normal menstrual cycle, e.g., infections or uterine causes. Uterine 
factors, such as myomas, are in turn favoured by hormonal imbalances so that here the 
transitions are fluent. If a disturbed ovarian function is present, an exact diagnosis could be 
made through laboratory determination of most of the important hormones. According to 
WHO, ovarian insufficiencies are classified in seven groups (7). To be specific, it relates to a 
classification of the amenorrhoeas. The individual endocrine disease pattern can also be 
reflected in menstrual rhythm abnormalities, such as oligomenorrhoeas or 
polymenorrhoeas. The exact knowledge of at what level the disorder is present is 
indispensible in order to be able to initiate an effective therapy. 
10. Hypogonadotropic ovarian dysfunction 
Hypogonadotropic amenorrhoea is usually functional (WHO Group I), with organic causes 
(Group VII) such as tumours or traumas are rare. A disturbed pulsatility of the GnRH 
secretion can lead to an insufficient FSH and LH production and consequently results in 
follicle maturation disorder. The causes for the functional disorder are extreme stress 
situations, such as anorexia nervosa, famines (war amenorrhoea) or intense physical 
exercise, such as competitive sports. An amenorrhoea is usually present but 
oligomenorrhoea is also possible. 
10.1 Diagnostics 
 Estimation of FSH, LH, estradiol, progesterone, prolactin, testosterone, androstendione, 
DHEAS and TSH: 
- Decreased gonadotropines, estradiol is also low. 
- A low level of progesterone points to a pre-ovulatory or ovarian dormancy. 
- To exclude hyperprolactinaemia and/or hyperandrogenaemia, determination of 
androgens and of prolactin should be considered. 
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- TSH levels to exclude altered thyroid gland function.  
 Due to suspected organic causes (additional symptoms such as headaches, impaired 
vision or dizziness and/or no functional cause for the hypogonadotropic situation) a 
MRT examination should be carried out. 
 A GnRH test can be carried out in order to eliminate the possible hypothalamic or 
pituitary causes (3). 
10.2 Therapy 
In case of organic causes if necessary, an operation is indicated. In case of functional 
disorders, a causal treatment such as weight gain in the case of anorexia should be strived 
for if possible. In addition, in case of low estradiol levels, HRT should be indicated and if 
there is a desire to have children, hormonal stimulation should be indicated if necessary. 
11. Hypergonadotropic ovarian dysfunction 
WHO Group III represents the hypergonadotropic ovarian insufficiencies. If secondary 
oligomenorrhoea or amenorrhoea is present then (physiological) perimenopausal situation 
and/or premature failure of the ovarian function (age > 40) can be thought of (increased 
FSH and LH levels). 
11.1 Diagnostics 
 Determination of FSH, LH, estradiol, progesterone, prolactin, testosterone, 
androstendione, DHEAS and TSH: 
- FSH and/or LH are elevated, estradiol low 
- A low level of progesterone indicates a pre-ovulatory or ovarian dormancy 
- To exclude hyperprolactinaemia and/or hyperandrogenaemia as well as 
dysfunction of the thyroid gland, determination of androgens, prolactin and TSH is 
essential. 
 Due to suspected POF, further diagnostic investigations (e.g., chromosome analysis to 
exclude Turner syndrome, search of autoimmune diseases or associated 
endocrinopathies) are essential. 
11.2 Therapy 
In case of young patients, there is an indication for hormone replacement therapy in order to 
avoid oestrogen-deficient situations. If there is a desire to have children, a hormonal 
stimulation with FSH can be tried depending on the starting situation, however, with little 
prospect for success. 
12. Hyperprolactinaemia 
Hyperprolactinaemic ovarian dysfunctions can be due to many causes. If the disorder is 
pronounced, an amenorrhoea can be present, in most cases however, there are menstrual 
irregularities such as oligomenorrhoeas or anovulatory eumenorrhoeas. If there is an 
ovarian insufficiency caused by prolactinoma it must be allocated to WHO Group V. The 
amenorrhoeas which are caused by drugs or other hyperprolatinaemic amenorrhoeas are 
allocated to WHO Group VI. Increased prolactin levels lead to an ovarian dysfunction 
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through a disturbed GnRH pulsatility but also through an influence on the adrenal cortex in 
terms of inducing adrenocortical hyperandrogenaemia. 
12.1 Diagnostics 
 Determination of FSH, LH, estradiol, progesterone, prolactin, testosterone, 
androstendione, DHEAS and TSH: 
- Gonadotropins and estradiol are usually normal or decreased 
- Prolactin is increased, in case of values > 50 ng/ml an image diagnosis should be 
included. 
- An associated hyperandrogenaemia can occur 
 Hypothyroidisms can lead to a hyperprolactinaemia through an increased release of TRH.  
 To measure a latent hyperprolactinaemia (normal basic prolactin values) provocation 
tests such as metoclopramide test can be carried out. 
12.2 Therapy 
If possible, a causal therapy (changeover of medication) should be strived for, however, the 
treatment with dopamine agonists is indicated in most cases. 
13. Hyperandogenaemic ovarian dysfunction 
The most common form of hyperandrogenaemic ovarian dysfunction (WHO Group II) is 
represented by the PCO syndrome. Ovarian insufficiencies of WHO Group II include all 
disorders with normal FSH levels where the interplay of gonadotropins or other factors of 
the central ovarian regulation (with the exception of hyperprolactinaemia) is disturbed. One 
main part of this group creates the hyperandrogenaemic disorders (2). The PCO syndrome 
is not a disease per se, rather a complex comprised of several symptoms. According to the 
Rotterdam classification from 2003, two of the three criteria must be present so that the 
PCOS diagnosis can be made (10): 
 Oligoovulation or anovulation 
 Clinical and/or biochemical sign of hyperandrogenisation 
 Polycystic ovaries and the exclusion of other causes (congenital adrenal hyperplasia, 
androgen producing tumours, Cushing disease). 
In case of PCOS, different causes can lead to a similar disease pattern. The most common 
menstrual irregularity in case of PCO syndrome is represented by oligomenorrhoea. In case 
of insufficient follicle maturation, an amenorrhoea can also be present. Even 
polymenorrhoea is possible through follicular disorder without ovulation or with 
consecutive corpus luteum insufficiency.  
13.1 Diagnostics 
 Determination of FSH, LH, estradiol, progesterone, prolactin, testosterone, 
androstendione, DHEAS, 17-OH-progesterone and TSH: 
- LH/FSH > 1.5-2 
- Estradiol can be normal, decreased or even elevated 
- Hyperandrogenaemia, depending on the individual androgens, can be 
differentiated with the knowledge of their production areas (ovarian and adrenal 
hyperandrogenaemia). 
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 An ACTH test to exclude late onset AGS should take place if there is an increase of 17-
OH-progesterone. A molecular genetic inspection can be carried out in the case of a 
striking ACTH test. The heterozygous form of 21 hydroxylase deficiency (most 
common cause for late-onset AGS) often remains latent during childhood. It manifests 
itself in women usually after puberty in the form of menstruation irregularities, 
androgenisation appearance or a PCO syndrome. 
13.2 Therapy 
Depending on the cause, living situation and symptoms, an antiandrogen ovulation 
inhibitor, ovarian stimulation with clomiphene, low dose FSH or corticosteroid treatment 
comes into question. 
14. Corpus luteum insufficiency 
Corpus luteum insufficiency relates to the normogonadotropic ovarian dysfunction. The 
cause for this is usually a follicle maturation disorder in the first half of the menstrual cycle 
which can lead to an insufficient formation of the corpus luteum. The luteal phase is 
shortened to less than 10 days so that it leads to a shortening of the cycle. Often 
premenstrual spotting is evident. The progesterone levels are too low. In the perimenopause 
phase, similar situation appears (physiological). However, the development of myomas or 
an endometriumperplasia, which in turn can aggravate the bleeding disorder, can be 
favoured through the relative progesterone deficiency. Corpus luteum insufficiency can be 
concomitant of other endocrine disorders. In case of a desire to have children, the cause 
should be carefully searched for.  
14.1 Diagnostics 
 Determination of progesterone in the mid-luteal phase (repeated > 10 ng/ml) 
 For differential diagnosis BHA with FSH, LH, estradiol, prolactin, testosterone, 
androstendione, DHEAS and TSH are to be carried out: 
- FSH, LH and estradiol within the normal range 
- The determination of androgens, prolactin and TSH to be made to exclude 
hyperprolactinaemia and/or hyperandrogenaemia as well as dysfunction of the 
thyroid gland. 
 If basal body temperature is managed (> 10 days of luteal phase).  
14.2 Therapy 
When planning to have children, an ovarian stimulation therapy can lead to an improved 
follicle maturation and more efficient formation of the corpus luteum. 
15. Dysfunctions of the thyroid gland 
Dysfunctions of the thyroid gland can lead to menstrual irregularities through the 
influence of the hypothalamic-pituitary system (WHO Group II). Hypothyroidism in 
particular is very important for gynaecological endocrinology. Clinical symptoms such as 
cold intolerance, reduced performance or dry, cold skin may confirm the diagnosis of 
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hypothyroidism. Hyperthyroidism can become noticeable through heat intolerance, moist 
and warm skin or tachycardias. Menstrual irregularities can occur in both the 
circumstances.  
15.1 Diagnostics 
 Determination of FSH, LH, estradiol, progesterone, prolactin, testosterone, 
androstendione, DHEAS and TSH: 
- Hypothyroidism: TSH increased, hyperthyroidism: TSH decreased 
- Gonadotropins can be normal or depleted 
- Hyperprolactinaemia possible 
- Hyperandrogenaemia possible 
 A TRH test should be carried out. 
15.2 Therapy 
If a dysfunction of the thyroid gland is diagnosed, dysfunction-related treatment should be 
installed and continued. In case of good thyroid function, repeated basal hormonal analysis 
is recommended. 
16. Conclusion for the practice 
Menstrual irregularities are usually contingent on ovarian dysfunction. The level of disorder 
can be identified after excluding organic causes through a basal hormonal analysis and thus 
an adequate therapy can be introduced. This chapter describes which hormones should be 
evaluated (11). 
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